ArticleScientific reports2021

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients.

Ulrich Jehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.